Compensation expense for the Company’s share-based plans was as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | July 4, 2026 | | June 28, 2025 | | July 4, 2026 | | June 28, 2025 | | Share-based compensation expense included in: | | | | | | | | | Costs of sales | $ | 22 | | | $ | 14 | | | $ | 43 | | | $ | 28 | | | Selling, general and administrative expenses | 57 | | | 40 | | | 111 | | | 75 | | | Research and development expenditures | 25 | | | 20 | | | 50 | | | 37 | | | Share-based compensation expense included in Operating earnings | 104 | | | 74 | | | 204 | | | 140 | | | Tax benefit | (17) | | | (15) | | | (35) | | | (29) | | | Share-based compensation expense, net of tax | $ | 87 | | | $ | 59 | | | $ | 169 | | | $ | 111 | | | Decrease in basic earnings per share | $ | (0.52) | | | $ | (0.35) | | | $ | (1.02) | | | $ | (0.67) | | | Decrease in diluted earnings per share | $ | (0.52) | | | $ | (0.35) | | | $ | (1.01) | | | $ | (0.66) | | | | | | | | | |
|